Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -91.83% vs -62.37% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 0.70% vs 106.52% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 37.73% vs 6.77% in Mar 2025
Compare Balance Sheet Results of Vilin Bio Med
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
15.25
20.00
-4.75
-23.75%
Share Warrants & Outstandings
Total Reserve
13.12
60.57
-47.45
-78.34%
Shareholder's Funds
28.37
80.58
-52.21
-64.79%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.13
-0.27
0.40
148.15%
Other Long Term Liabilities
0.00
0.30
-0.30
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.13
0.03
0.10
333.33%
Current Liabilities
Trade Payables
3.35
2.44
0.91
37.30%
Other Current Liabilities
2.88
3.35
-0.47
-14.03%
Short Term Borrowings
0.21
0.00
0.21
0.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
6.44
5.79
0.65
11.23%
Total Liabilities
34.94
86.40
-51.46
-59.56%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
11.26
2.72
8.54
313.97%
Less: Accumulated Depreciation
8.39
1.58
6.81
431.01%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.87
1.14
1.73
151.75%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.20
-0.20
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
2.51
-2.51
-100.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
4.69
10.74
-6.05
-56.33%
Total Non-Current Assets
7.56
14.60
-7.04
-48.22%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
7.22
0.83
6.39
769.88%
Sundry Debtors
15.96
20.90
-4.94
-23.64%
Cash and Bank
1.47
47.37
-45.90
-96.90%
Other Current Assets
2.31
0.42
1.89
450.00%
Short Term Loans and Advances
0.43
2.28
-1.85
-81.14%
Total Current Assets
27.38
71.80
-44.42
-61.87%
Net Current Assets (Including Current Investments)
20.94
66.01
-45.07
-68.28%
Total Current Assets Excluding Current Investments
27.38
71.80
-44.42
-61.87%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
34.94
86.40
-51.46
-59.56%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.21
0.00
0.21
0.00%
Book Value per share (adjusted)
0.00
40.28
-40.28
-100.00%
Annual - Borrowings
Borrowings 0.21 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -91.83% vs -62.37% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 2.87 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.70% vs 106.52% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 27.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 37.73% vs 6.77% in Mar 2025
Footer loading
